Social Capital Suvretta Holdings Corp IV Cl A (DNAD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | DNAD | LCTX | ELDN | ||
| Company | Social Capital Suvretta Holdings Corp IV Cl A | Lineage Cell Therapeutics Inc | Eledon Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE Arca | NASDAQ | ||
| Open | 10.35 | 1.3400 | 4.20 | ||
| High | 10.36 | 1.3500 | 4.24 | ||
| Low | 10.34 | 1.2800 | 4.07 | ||
| Latest | 10.35 | 1.3050 | 4.14 | ||
| Change | +0.01 | -0.0350 | -0.07 | ||
| % Change | +0.10% | -2.61% | -1.66% | ||
| Volume | 144,200 | 267,772 | 376,342 | ||
| 20-Day Average Volume | 127,825 | 2,147,978 | 1,859,370 | ||
| Previous Close | 10.34 | 1.3400 | 4.21 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 10.33 | 1.2767 | 3.81 | ||
| 20-Day Raw Stochastic | 83.33% | 52.78% | 66.22% | ||
| 20-Day Relative Strength | 65.52 | 48.68 | 58.88 | ||
| Weighted Alpha | +6.50 | +5.01 | +99.95 | ||
| Today's Opinion | 100% Buy | 72% Sell | 100% Buy | ||
| Previous Opinion | 100% Buy | 56% Sell | 100% Buy | ||
| Last Month's Opinion | 100% Buy | 100% Sell | 72% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.15% since 06/23/23 | -0.38% since 07/01/26 | +5.51% since 07/01/26 | ||
| Low | 10.33 on 06/28/23 | 1.2900 on 07/02/26 | 3.82 on 07/02/26 | ||
| High | 10.36 on 06/30/23 | 1.3800 on 07/06/26 | 4.26 on 07/08/26 | ||
| 1-Month | |||||
| %Chg | +0.38% since 05/30/23 | +6.15% since 06/09/26 | +15.92% since 06/09/26 | ||
| Low | 10.30 on 06/01/23 | 1.2000 on 06/26/26 | 3.38 on 06/11/26 | ||
| High | 10.36 on 06/30/23 | 1.3800 on 07/06/26 | 4.49 on 06/22/26 | ||
| 3-Month | |||||
| %Chg | +1.27% since 03/30/23 | -13.09% since 04/09/26 | +32.74% since 04/09/26 | ||
| Low | 10.22 on 04/10/23 | 1.1800 on 06/09/26 | 3.07 on 04/10/26 | ||
| High | 10.46 on 04/12/23 | 1.7500 on 04/17/26 | 4.49 on 06/22/26 | ||
| 6-Month | |||||
| %Chg | +2.99% since 12/30/22 | -24.27% since 01/09/26 | +137.86% since 01/09/26 | ||
| Low | 10.04 on 01/04/23 | 1.1800 on 06/09/26 | 1.70 on 01/13/26 | ||
| High | 10.92 on 01/12/23 | 1.9850 on 03/02/26 | 4.49 on 06/22/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 330,061 | 334,059 | 324,962 | ||
| Shares Outstanding, K | 31,890 | 249,298 | 77,188 | ||
| Annual Sales | 0 | 14,560,000 | 0 | ||
| Annual Net Income | 2,740,000 | -63,530,000 | -45,620,000 | ||
| Last Quarter Sales | 0 | 1,730,000 | 0 | ||
| Last Quarter Net Income | 2,460,000 | -4,810,000 | -39,030,000 | ||
| 60-Month Beta | 0.01 | 1.51 | 0.95 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 05/15/23 | -0.03 on 05/12/26 | -0.16 on 05/13/26 | ||
| Earnings Date | 01/01/70 | 08/11/26 | 08/13/26 | ||
| Most Recent Dividend | N/A | 0.080 on 12/15/03 | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||